characteristics.text: SAMN42652299
characteristics.characteristic: External Id
characteristics.text: dbGaP
characteristics.characteristic: INSDC center name
characteristics.text: 2024-07-19T16:06:34.287Z
characteristics.characteristic: INSDC first public
characteristics.text: 2024-09-24T08:15:26.643Z
characteristics.characteristic: INSDC last update
characteristics.text: SRS22071373
characteristics.characteristic: INSDC secondary accession
characteristics.text: live
characteristics.characteristic: INSDC status
characteristics.text: Generic
characteristics.characteristic: NCBI submission model
characteristics.text: Generic.1.0
characteristics.characteristic: NCBI submission package
characteristics.text: SRS22071373
characteristics.characteristic: SRA accession
characteristics.text: RNA
characteristics.characteristic: analyte type
characteristics.text: NCI_BotensilimabEfficacy
characteristics.characteristic: biospecimen repository
characteristics.text: sam-4807_T
characteristics.characteristic: biospecimen repository sample id
characteristics.text: ABDOMINAL WALL MASS
characteristics.characteristic: body site
characteristics.text: phs003704
characteristics.characteristic: gap_accession
characteristics.text: 1
characteristics.characteristic: gap_consent_code
characteristics.text: GRU-NPU
characteristics.characteristic: gap_consent_short_name
characteristics.text: 6236120
characteristics.characteristic: gap_sample_id
characteristics.text: 4966749
characteristics.characteristic: gap_subject_id
characteristics.text: Yes
characteristics.characteristic: is tumor
characteristics.text: Homo sapiens
characteristics.ontologyTerms: http://purl.obolibrary.org/obo/NCBITaxon_9606
characteristics.characteristic: organism
characteristics.text: Clinical Trial
characteristics.characteristic: study design
characteristics.text: Botensilimab, an Fc-enhanced Anti-CTLA-4 Antibody, is Effective Against Tumors Poorly Responsive to Conventional Immunotherapy
characteristics.characteristic: study name
characteristics.text: sam-4807_T
characteristics.characteristic: submitted sample id
characteristics.text: sam-4807
characteristics.characteristic: submitted subject id
characteristics.text: NCI_BotensilimabEfficacy
characteristics.characteristic: submitter handle
characteristics.text: Tumor RNA sample from ABDOMINAL WALL MASS of a human participant in the dbGaP study "Botensilimab, an Fc-enhanced Anti-CTLA-4 Antibody, is Effective Against Tumors Poorly Responsive to Conventional Immunotherapy"
characteristics.characteristic: title